This PT-141 + MT-2 peptide blend contains 1.5 mg of PT-141 (Bremelanotide) and 0.6 mg of Melanotan II (MT-2), supporting advanced laboratory research into melanocortin-receptor signaling and neuropeptide-mediated biological pathways. PT-141 is commonly used by researchers to investigate central melanocortin activation and neurochemical communication within controlled experimental systems. MT-2 is a stable cyclic analogue of α-MSH used to study receptor affinity, pigmentation mechanisms, and neuroendocrine signaling.
Researchers value the PT-141 + MT-2 peptide blend for its ability to facilitate studies of both central and peripheral melanocortin pathways. This combination supports detailed mechanistic analysis of melanin-linked signaling, receptor interaction kinetics, and neurobiological communication across multiple model types.
Common research applications include:
Mapping melanocortin receptor activity and selectivity
Analysing neurochemical signaling cascades in vitro or ex vivo
Studying peptide-driven biological responses in controlled environments
Comparing dual-pathway interactions with single-compound controls
Because both peptides provide clearly defined behavior in regulated laboratory conditions, the blend enables repeatable performance, structured dose control, and precise signaling-pathway monitoring. It is suitable for research programs requiring high-purity materials and consistent data output.
This product is supplied exclusively for accredited laboratory research. It is not approved for human or veterinary administration, therapeutic use, or diagnostic application. All handling must follow institutional biosafety practices and applicable regulatory standards.
For research use only. Not for human consumption.
Not a researcher? Exit
